Munich Re upgraded to “overweight” on ROE outlook, €650 price target

J.P. Morgan upgraded Munich Re to "overweight" and raised its price target to €650 from €530, citing expectations of improved return on equity (ROE), higher capital returns, and a more diversified earnings mix. The upgrade is driven by an anticipated new strategic plan targeting 16-18% ROE, significant capital returns via share buybacks increasing to €4 billion by 2028 due to over €12 billion in surplus capital (285% Solvency II ratio), and a strategic shift in earnings away from P&C reinsurance towards life and specialty segments. Despite softening P&C rates, Munich Re's diversification and projected improvements in combined ratios are expected to drive EPS growth, with the stock currently trading at a 7% discount to the sector on forward P/E.

Analysis

J.P. Morgan's upgrade of Munich Re to "overweight" with a raised price target of €650 is predicated on a multi-faceted thesis of improving profitability, substantial capital returns, and strategic earnings diversification. The brokerage anticipates a new strategic plan will target a higher Return on Equity of 16–18%, a notable increase from the current 14–16% goal. This optimism is underpinned by a robust capital position, evidenced by a Q1 2025 Solvency II ratio of 285%, which implies over €12 billion in surplus capital. This surplus is expected to fuel a significant increase in share buybacks, forecasted to rise from €2.5 billion in 2025 to €4 billion by 2028, pushing the total capital return yield to 9.5% by 2027—well above the sector average of approximately 7%. Concurrently, Munich Re is strategically de-risking its earnings profile by reducing its reliance on P&C reinsurance, with its contribution to operating profit projected to fall from 53% in 2024 to 45% by 2028, while growing its life, specialty, and international insurance segments. While property catastrophe reinsurance rates are softening, with a 7% decline in January 2025, this is viewed as a manageable headwind due to the company's diversification. The stock's current valuation at a 7% forward P/E discount to the sector, a reversal from its 10-year average premium, presents a compelling entry point relative to its enhanced earnings and capital return outlook.

Key Decisions for Investors

• Given the strong capital return outlook, forecasted EPS growth, and current valuation discount relative to peers and its own history, investors could consider the stock for potential capital appreciation and view the J.P. Morgan upgrade as a positive catalyst.
• For income-oriented portfolios, the projected rise in the capital return yield to 9.5% by 2027, driven by a combination of increasing dividends and aggressive share buybacks, makes Munich Re an attractive holding.
• Investors should monitor the company's strategic update on December 11, 2025, for confirmation of the higher ROE targets, and track the impact of softening reinsurance rates on profitability to ensure the diversification strategy effectively mitigates this headwind.